Oncimmune Investors
Oncimmune engaged in developing and commercializing its EarlyCDT platform technology.
Founded Date:
2006
Technology:
Advanced Longevity (R&D)
Headquarters:
Nottingham, Nottingham, United Kingdom
Investor Type:
Information Technology Corporation
Industry:
Advanced and Next Generation Therapies (Various)